Français
ItalianoBond GSK PLC 3.375% ( US36264FAC59 ) in USD
| Issuer | GSK PLC | ||||||
| Market price |  89.601 % ⇌ |
||||||
| Country |  United Kingdom
|
||||||
| ISIN code |
 US36264FAC59 ( in USD )
|
||||||
| Interest rate | 3.375% per year ( payment 2 times a year) | ||||||
| Maturity | 03/24/2029 | ||||||
| Minimal amount | 250 000 USD | ||||||
| Total amount | 1 000 000 000 USD | ||||||
| Cusip | 36264FAC5 | ||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||
| Next Coupon | 03/24/2027 ( In 151 days ) | ||||||
| Detailed description |
GSK PLC is a British multinational pharmaceutical and biopharmaceutical company headquartered in Brentford, UK, focused on research and development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products globally. The Bond issued by GSK PLC ( United Kingdom ) , in USD, with the ISIN code US36264FAC59, pays a coupon of 3.375% per year. The coupons are paid 2 times per year and the Bond maturity is 03/24/2029 The Bond issued by GSK PLC ( United Kingdom ) , in USD, with the ISIN code US36264FAC59, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by GSK PLC ( United Kingdom ) , in USD, with the ISIN code US36264FAC59, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||